Phase II Clinical Trial of Vitamin D3 for Reducing Recurrence of Recurrent Lower Urinary Tract Infections
Status:
Recruiting
Trial end date:
2023-07-30
Target enrollment:
Participant gender:
Summary
The aim of this study was to initially evaluate the optimal dose, efficacy, and safety of
vitamin D3 for reducing recurrence of recurrent urinary tract infections (rUTIs).
Phase:
Phase 2
Details
Lead Sponsor:
Zensun Sci. & Tech. Co., Ltd.
Treatments:
Anti-Bacterial Agents Cholecalciferol Ergocalciferols Vitamin D Vitamins